Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors.
about
Resveratrol and clinical trials: the crossroad from in vitro studies to human evidenceAn Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of ResveratrolBenzylglucosinolate Derived Isothiocyanate from Tropaeolum majus Reduces Gluconeogenic Gene and Protein Expression in Human CellsThe Anti-Cancer Effect of Polyphenols against Breast Cancer and Cancer Stem Cells: Molecular MechanismsDietary antiaging phytochemicals and mechanisms associated with prolonged survivalResveratrol inhibits β-amyloid-induced neuronal apoptosis through regulation of SIRT1-ROCK1 signaling pathwayResveratrol and cancer: focus on in vivo evidence.Conformational changes and translocation of tissue-transglutaminase to the plasma membranes: role in cancer cell migration.Improving In Vivo Efficacy of Bioactive Molecules: An Overview of Potentially Antitumor Phytochemicals and Currently Available Lipid-Based Delivery Systems.Epigenetic modifications by dietary phytochemicals: implications for personalized nutritionFoxO3a and disease progression.Aging and dry eye diseaseMicroRNA-96 inhibits FoxO3a function in IPF fibroblasts on type I collagen matrix.Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells.The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome.Ras and Rac1, frequently mutated in melanomas, are activated by superoxide anion, modulate Dnmt1 level and are causally related to melanocyte malignant transformation.Resveratrol Protects against TNF-α-Induced Injury in Human Umbilical Endothelial Cells through Promoting Sirtuin-1-Induced Repression of NF-KB and p38 MAPK.Chemoprevention in gastrointestinal physiology and disease. Targeting the progression of cancer with natural products: a focus on gastrointestinal cancer.Role of epigenetic modifications in luminal breast cancer.Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo.EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin.Dietary components as epigenetic-regulating agents against cancerChemopreventive effect of resveratrol and apocynin on pancreatic carcinogenesis via modulation of nuclear phosphorylated GSK3β and ERK1/2Chemoprevention of gastrointestinal cancer: the reality and the dream.Pancreatic cancer chemoprevention by phytochemicalsNatural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers.In vitro comparative studies of resveratrol and triacetylresveratrol on cell proliferation, apoptosis, and STAT3 and NFκB signaling in pancreatic cancer cells.YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine.Resveratrol accelerates erythroid maturation by activation of FoxO3 and ameliorates anemia in beta-thalassemic mice.Rapid dramatic alterations to the tumor microstructure in pancreatic cancer following irreversible electroporation ablationCasticin induces breast cancer cell apoptosis by inhibiting the expression of forkhead box protein M1.Dietary phytochemicals alter epigenetic events and signaling pathways for inhibition of metastasis cascade: phytoblockers of metastasis cascade.Plant natural products: from traditional compounds to new emerging drugs in cancer therapy.Resveratrol in the treatment of pancreatic cancer.Targeting reactive oxygen species in development and progression of pancreatic cancer.Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence.Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression.Anticancer Natural Compounds as Epigenetic Modulators of Gene ExpressionMelatonin induces transcriptional regulation of Bim by FoxO3a in HepG2 cells.Sirtuin 1-dependent resveratrol cytotoxicity and pro-differentiation activity on breast cancer cells.
P2860
Q24618313-71CE1A36-7EB7-4B65-B578-57A874D7CFA5Q26800907-E20A5C51-0862-443C-BF75-964B1F249EE7Q27323729-2FFD60F3-CC2E-40D9-BB92-C91C86C8E6A0Q28066752-606DF9AD-8A00-4C97-8E4B-EA92209DBEA4Q28385788-477058CC-29F8-4144-AD05-3623344BC11EQ28489106-6A77F738-1FC3-420C-82B3-1C54661C41BBQ33578943-E59F7E3C-7A10-4BE8-908A-1BF03C5CAFD7Q33611930-FDF99891-6F0E-4314-B738-DB366C3D0890Q33710442-A17AC314-3802-4906-89B7-86CDDA1ECB83Q34129835-343B53FE-B38B-49F3-9BFD-65CF8B4164BBQ34161585-2F9A3E8C-B2B8-4FE1-ADC6-BD0E5761B55BQ34273593-ECEBAD10-8357-442D-9D3B-47D604DC023BQ34356445-57FA4002-6DF5-45C1-9A50-12D5FC6AFCB3Q34518736-2A4DB9DB-8189-42BD-B193-C6095DC0C3A6Q34690409-AB61B1D0-4202-4E38-BDBA-41C3D8974D4CQ35072584-F0B3BF25-3675-4098-8B7D-5CA81619A50FQ35901482-F3814DA0-A9BA-45AE-B752-731A2E7EB213Q35928052-B3205FDE-1707-499E-BCF5-475C5533B296Q35963443-2CF9A4E4-4A82-4521-A19E-53A7839E67D1Q36354217-4A5215C3-19F0-4800-984C-930182531A35Q36429059-77DF4073-8CC3-44D2-AFCD-795106F43EFFQ36576975-5F49D056-7B5E-4811-A133-5DE97EF0B213Q36619084-8B879398-73D4-46CE-A356-1ED61C90747DQ36715105-D2BB81EA-E910-4D65-BC0C-7039113AE508Q36763100-3408EE13-0721-41F6-A97E-4ABF64041396Q37114055-3F72159C-2A72-4A54-82BA-611139893DAAQ37188949-E5AEF6EE-084A-4C7A-8612-0F5CAC80C573Q37373749-017DF4B4-B3E8-4197-9A59-1AE8940FBF91Q37552018-BA82D3E7-B9CA-4043-9615-74DA0CFDBCBDQ37634294-4982DF46-9D93-43A0-AC1E-1082914D1F77Q37719958-CBF4C84C-DA5A-4125-891C-0F10E614E6ADQ38175845-7637BD6A-B576-4851-9A03-454981751A39Q38265836-CB0B795D-E8F4-4DC7-B81F-20419D8830C5Q38568979-A9B4DA57-C8E1-44E7-9C30-5F5C47E30191Q39007517-3A2D4039-51AF-49CB-A293-4E67A2EC1A4AQ39088576-C897132C-63F8-4EBD-8BFC-2FDA3D79F6D0Q39202824-5AD0814D-A82C-4D37-9F97-2E979F97ACD6Q39214234-06DB5733-4427-47FC-812B-5A9CB2BFB470Q39222725-BFDBE9AF-D990-4CDA-9671-00B63EAE7D1AQ39643937-E3678A00-1476-45F3-91AB-C11FB1F0A5B4
P2860
Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Resveratrol inhibits growth of ...... of FOXO transcription factors.
@ast
Resveratrol inhibits growth of ...... of FOXO transcription factors.
@en
Resveratrol inhibits growth of ...... of FOXO transcription factors.
@nl
type
label
Resveratrol inhibits growth of ...... of FOXO transcription factors.
@ast
Resveratrol inhibits growth of ...... of FOXO transcription factors.
@en
Resveratrol inhibits growth of ...... of FOXO transcription factors.
@nl
prefLabel
Resveratrol inhibits growth of ...... of FOXO transcription factors.
@ast
Resveratrol inhibits growth of ...... of FOXO transcription factors.
@en
Resveratrol inhibits growth of ...... of FOXO transcription factors.
@nl
P2093
P2860
P1433
P1476
Resveratrol inhibits growth of ...... of FOXO transcription factors.
@en
P2093
Junsheng Fu
Qinghe Chen
Rakesh K Srivastava
Sanjit K Roy
Sharmila Shankar
P2860
P304
P356
10.1371/JOURNAL.PONE.0025166
P407
P577
2011-09-27T00:00:00Z